<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>lentiviral vectors &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/lentiviral-vectors/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 18 Oct 2026 13:57:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>lentiviral vectors &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>In vivo CAR-T therapy aims to turn bespoke living drugs into universal genetic medicines</title>
		<link>https://bioengineer.org/in-vivo-car-t-therapy-aims-to-turn-bespoke-living-drugs-into-universal-genetic-medicines/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 18 Oct 2026 13:57:50 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[adeno-associated virus]]></category>
		<category><![CDATA[autoimmune disease]]></category>
		<category><![CDATA[Cancer immunotherapy]]></category>
		<category><![CDATA[CAR-T therapy]]></category>
		<category><![CDATA[cell therapy]]></category>
		<category><![CDATA[gene delivery]]></category>
		<category><![CDATA[Immunity & Inflammation]]></category>
		<category><![CDATA[in vivo T cell engineering]]></category>
		<category><![CDATA[lentiviral vectors]]></category>
		<category><![CDATA[lipid nanoparticles]]></category>
		<category><![CDATA[mRNA delivery]]></category>
		<category><![CDATA[viral vectors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=434910</guid>

					<description><![CDATA[A new review charts how in vivo CAR-T engineering could transform customized living drugs into scalable, off-the-shelf genetic medicines.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">434910</post-id>	</item>
	</channel>
</rss>
